Literature DB >> 3193129

Immortalized rat Schwann cells produce tumours in vivo.

L A Langford1, S Porter, R P Bunge.   

Abstract

We have recently reported the immortalization of primary Schwann cells isolated from sciatic nerves of normal neonatal rats. The cells were maintained under continuous mitogenic stimulation with glial growth factor and forskolin, achieving immortalization after 12 to 15 weeks without the use of viral infection, oncogene transformation or chemical carcinogens. The immortalized cells (1.17 cells) initially retain the capability to recognize and attach to peripheral neurons in culture as well as the ability to myelinate those neurons. The functional capacity of the cells gradually diminishes in culture, such that late passage cells can ensheath neurons but cannot form a myelin sheath. Both normal and immortalized cells secrete comparable amounts of autocrine growth factor activity in culture that can be regulated by extracellular matrix proteins. The difference between quiescent and immortalized Schwann cells seems to lie not in the production of growth factor but rather in the relative ability to respond to the factor(s). To test the potential of the immortalized Schwann cells for the ability to form tumours in vivo, we injected equal numbers of primary or immortalized Schwann cells into the sciatic nerve of adult syngenic rats and allowed them to incubate there for 6 to 13 weeks, whereupon the injected nerves were inspected for tumour formation. In every case (N = 3) the primary cells had no effect whereas every injection of immortalized cells (N = 5) resulted in a solid cellular mass surrounding the injected nerve. The tumours were encapsulated masses of actively dividing Schwann-like cells that surrounded but did not invade the nerve fascicle.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3193129     DOI: 10.1007/bf01189807

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  14 in total

Review 1.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

Review 2.  Strategies for achieving and monitoring myelin repair.

Authors:  Claire Rice; Neil Scolding
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

3.  Proceedings of the 2012 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Brian R Berridge; Michael C Boyle; Michelle C Cora; Mark J Hoenerhoff; Linda Kooistra; Victoria A Laast; James P Morrison; Deepa Rao; Matthias Rinke; Katsuhiko Yoshizawa
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902

4.  Antiproliferative function of glia maturation factor beta.

Authors:  R Lim; W X Zhong; A Zaheer
Journal:  Cell Regul       Date:  1990-09

Review 5.  Schwann cell tumors express characteristic patterns of CD44 splice variants.

Authors:  L Sherman; P Skroch-Angel; J Moll; K Schwechheimer; H Ponta; P Herrlich; M Hofmann
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

Review 6.  Therapeutic strategies in multiple sclerosis. II. Long-term repair.

Authors:  N Scolding
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

7.  Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression.

Authors:  D Muir
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

Review 8.  Human Schwann Cell Transplantation for Spinal Cord Injury: Prospects and Challenges in Translational Medicine.

Authors:  Paula V Monje; Lingxiao Deng; Xiao-Ming Xu
Journal:  Front Cell Neurosci       Date:  2021-06-18       Impact factor: 5.505

9.  Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth.

Authors:  G Zoidl; S Blass-Kampmann; D D'Urso; C Schmalenbach; H W Müller
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

10.  Development of a functional schwann cell phenotype from autologous porcine bone marrow mononuclear cells for nerve repair.

Authors:  Michael J Rutten; Michael Ann Janes; Ivy R Chang; Cynthia R Gregory; Kenton W Gregory
Journal:  Stem Cells Int       Date:  2012-06-24       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.